Patents/Inventors

Marc Van Dijk

Bosch en DuinNL11 patents

14 Patents

US124922572025
Anti-ctla-4 Antibodies and Methods of Use Thereof
MEMORIAL SLOAN-KETTERING CANCER CENTER
0 cites
US124923932025
Anti-cd137 Antibodies and Methods of Use Thereof
Memorial Sloan-kettering Cancer Center
0 cites
US123917412025
T Cell Receptors That Bind to Mixed Lineage Leukemia (mll)-specific Phosphopeptides and Methods of Use Thereof
Mink Therapeutics, Inc.
0 cites
US122460662025
Anti-ctla-4 Antibodies and Methods of Use Thereof
Memorial Sloan Kettering Cancer Center
0 cites
US121877952025
Anti-lag-3 Antibodies and Methods of Use Thereof
AGENUS Inc.
0 cites
US120114812024
Anti-tim-3 Antibodies and Methods of Use Thereof
AGENUS Inc.
0 cites
US119936512024
Anti-lag-3 Antibodies and Methods of Use Thereof
AGENUS Inc.
0 cites
US119936532024
Antibodies and Methods of Use Thereof
Memorial Sloan Kettering Cancer Center
0 cites
US118979622024
Anti-gitr Antibodies and Methods of Use Thereof
Ludwig Institute For Cancer Research Ltd.
0 cites
US118981652024
Engineered Host Cells and Methods of Use Thereof
Mink Therapeutics, Inc.
0 cites
US118396532023
Anti-tim-3 Antibodies and Methods of Use Thereof
AGENUS Inc.
0 cites
US117186582023
T Cell Receptors That Bind to Mixed Lineage Leukemia (mll)-specific Phosphopeptides and Methods of Use Thereof
Mink Therapeutics, Inc.
0 cites
US116387552023
Anti-ctla-4 Antibodies and Methods of Use Thereof
Memorial Sloan-kettering Cancer Center
0 cites
US116137642023
T Cell Receptors That Bind to NY-ESO-1 and Methods of Use Thereof
Mink Therapeutics, Inc.
0 cites